1. Home
  2. TECH vs ICL Comparison

TECH vs ICL Comparison

Compare TECH & ICL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • ICL
  • Stock Information
  • Founded
  • TECH 1976
  • ICL 1968
  • Country
  • TECH United States
  • ICL Israel
  • Employees
  • TECH N/A
  • ICL N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • ICL Agricultural Chemicals
  • Sector
  • TECH Health Care
  • ICL Industrials
  • Exchange
  • TECH Nasdaq
  • ICL Nasdaq
  • Market Cap
  • TECH 7.8B
  • ICL 8.8B
  • IPO Year
  • TECH 1989
  • ICL N/A
  • Fundamental
  • Price
  • TECH $46.66
  • ICL $6.47
  • Analyst Decision
  • TECH Buy
  • ICL Hold
  • Analyst Count
  • TECH 10
  • ICL 2
  • Target Price
  • TECH $73.44
  • ICL $6.75
  • AVG Volume (30 Days)
  • TECH 2.2M
  • ICL 722.7K
  • Earning Date
  • TECH 05-07-2025
  • ICL 05-19-2025
  • Dividend Yield
  • TECH 0.69%
  • ICL 2.85%
  • EPS Growth
  • TECH N/A
  • ICL N/A
  • EPS
  • TECH 0.83
  • ICL 0.30
  • Revenue
  • TECH $1,208,770,000.00
  • ICL $6,873,000,000.00
  • Revenue This Year
  • TECH $7.16
  • ICL $4.71
  • Revenue Next Year
  • TECH $6.36
  • ICL $4.08
  • P/E Ratio
  • TECH $59.68
  • ICL $21.79
  • Revenue Growth
  • TECH 4.72
  • ICL N/A
  • 52 Week Low
  • TECH $46.01
  • ICL $3.79
  • 52 Week High
  • TECH $83.96
  • ICL $6.95
  • Technical
  • Relative Strength Index (RSI)
  • TECH 39.06
  • ICL 43.11
  • Support Level
  • TECH $46.35
  • ICL $6.68
  • Resistance Level
  • TECH $49.92
  • ICL $6.89
  • Average True Range (ATR)
  • TECH 2.20
  • ICL 0.11
  • MACD
  • TECH 0.08
  • ICL -0.07
  • Stochastic Oscillator
  • TECH 4.80
  • ICL 13.39

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

Share on Social Networks: